Emcure Pharmaceuticals Limited — Others, 25-06-2025: Trading Window

Emcure Pharmaceuticals has announced a board meeting to approve the financial results for the quarter and half-year ending June 30, 2025. The company has also declared the trading window closed for its designated persons and their relatives starting July 1, 2025, until 48 hours after the results announcement. This trading restriction ensures compliance with internal policies on insider trading ahead of key financial disclosures, maintaining market integrity and shareholder confidence.